Sources | Names Used |
---|---|
CTRPv2 | selumetinib:PLX-4032 (8:1 mol/mol) |
PharmacoGx | selumetinib:PLX-4032 (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | IL21R | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
mRNA | C10orf11 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | LYPD8 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | DOLPP1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
mRNA | COPRS | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
mRNA | GTPBP3 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
mRNA | ACP6 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | SIRPD | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | GPT2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
mRNA | TIMM23B | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |